135 related articles for article (PubMed ID: 28001324)
1. Smart Microbubble Eluting Theranostic Stent for Noninvasive Ultrasound Imaging and Prevention of Restenosis.
Keum DH; Mun JH; Hwang BW; Kim J; Kim H; Jo W; Ha DH; Cho DW; Kim C; Hahn SK
Small; 2017 Mar; 13(10):. PubMed ID: 28001324
[TBL] [Abstract][Full Text] [Related]
2. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis.
Werner GS; Emig U; Krack A; Schwarz G; Figulla HR
Catheter Cardiovasc Interv; 2004 Nov; 63(3):259-64. PubMed ID: 15505841
[TBL] [Abstract][Full Text] [Related]
4. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
[TBL] [Abstract][Full Text] [Related]
6. Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS).
Jensen LO; Vikman S; Antonsen L; Kosonen P; Niemelä M; Christiansen EH; Kervinen K; Erglis A; Harnek J; Kumsars I; Thuesen L; Niemelä K
Cardiovasc Revasc Med; 2017 Dec; 18(8):577-582. PubMed ID: 29066343
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.
Mehilli J; Dibra A; Kastrati A; Pache J; Dirschinger J; Schömig A;
Eur Heart J; 2006 Feb; 27(3):260-6. PubMed ID: 16401670
[TBL] [Abstract][Full Text] [Related]
8. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
9. Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis.
Wang X; Gkanatsas Y; Palasubramaniam J; Hohmann JD; Chen YC; Lim B; Hagemeyer CE; Peter K
Theranostics; 2016; 6(5):726-38. PubMed ID: 27022419
[TBL] [Abstract][Full Text] [Related]
10. Differential impact of cilostazol on restenosis according to implanted stent type (from a pooled analysis of three DECLARE randomized trials).
Lee SW; Ahn JM; Han S; Park GM; Cho YR; Lee WS; Jang JY; Kwon CH; Lee JY; Kim WJ; Kang SJ; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2013 Nov; 112(9):1328-34. PubMed ID: 23890573
[TBL] [Abstract][Full Text] [Related]
11. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
Jensen LO; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L
Eur Heart J; 2008 Nov; 29(22):2733-41. PubMed ID: 18832385
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and Patterns of Intravascular Ultrasound In-Stent Restenosis Among Bare Metal Stents and First- and Second-Generation Drug-Eluting Stents.
Goto K; Zhao Z; Matsumura M; Dohi T; Kobayashi N; Kirtane AJ; Rabbani LE; Collins MB; Parikh MA; Kodali SK; Leon MB; Moses JW; Mintz GS; Maehara A
Am J Cardiol; 2015 Nov; 116(9):1351-7. PubMed ID: 26341188
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Park SJ; Lee JH; Choi SW; Seong IW; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Choi YJ; Kim HS; Lee BK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Park WJ;
J Am Coll Cardiol; 2011 Mar; 57(11):1264-70. PubMed ID: 21392640
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.
Ardissino D; Cavallini C; Bramucci E; Indolfi C; Marzocchi A; Manari A; Angeloni G; Carosio G; Bonizzoni E; Colusso S; Repetto M; Merlini PA;
JAMA; 2004 Dec; 292(22):2727-34. PubMed ID: 15585732
[TBL] [Abstract][Full Text] [Related]
15. Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents.
Kufner S; Massberg S; Dommasch M; Byrne RA; Tiroch K; Ranftl S; Fusaro M; Schömig A; Kastrati A; Mehilli J;
Catheter Cardiovasc Interv; 2011 Aug; 78(2):161-6. PubMed ID: 21400652
[TBL] [Abstract][Full Text] [Related]
16. Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents.
Roy P; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Torguson R; Xue Z; Gevorkian N; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
Am J Cardiol; 2007 Sep; 100(6):965-9. PubMed ID: 17826379
[TBL] [Abstract][Full Text] [Related]
17. Comparison of stent graft, sirolimus stent, and bare metal stent implanted in patients with acute coronary syndrome: clinical and angiographic follow-up.
Strozzi M; Anić D
Croat Med J; 2007 Jun; 48(3):348-52. PubMed ID: 17589978
[TBL] [Abstract][Full Text] [Related]
18. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
[TBL] [Abstract][Full Text] [Related]
19. A paclitaxel-eluting stent for the prevention of coronary restenosis.
Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
[TBL] [Abstract][Full Text] [Related]
20. Intravascular ultrasound stent area of sirolimus-eluting stents and its impact on late outcome.
Cheneau E; Pichard AD; Satler LF; Suddath WO; Weissman NJ; Waksman R
Am J Cardiol; 2005 May; 95(10):1240-2. PubMed ID: 15878001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
